Emergent BioSolutions (EBS) EPS (Basic) (2011 - 2026)
Emergent BioSolutions' (EBS) quarterly EPS (Basic) came in at $0.13 in Q1 2026, down 89.52% year-on-year from $1.25 in Q1 2025, and up 112.84% quarter-over-quarter from -$1.02 in Q4 2025.
Emergent BioSolutions (EBS) EPS (Basic) (2011 - 2026) Analysis & Trends
Emergent BioSolutions' EPS (Basic) history runs 15 years deep, the most recent figure standing at $0.13 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 89.52% year-over-year to $0.13 in Q1 2026; TTM through Mar 2026 was -$0.17, a 93.15% increase from a year earlier, with the FY2025 full-year figure at $0.98, up 127.34% from the prior year.
- EPS (Basic) climbed to $0.13 in Q1 2026 per EBS's latest filing, from -$1.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.16 in Q3 2024 and bottomed at -$5.38 in Q2 2024.
- The 5-year median for EPS (Basic) is -$0.97 (2023), against an average of -$1.28.
- Across the five-year window, EPS (Basic) tumbled 4982.56% in 2023 and jumped 625.0% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$1.34 in 2022, then climbed by 27.71% to -$0.97 in 2023, then soared by 38.92% to -$0.59 in 2024, then slumped by 72.81% to -$1.02 in 2025, then soared by 112.84% to $0.13 in 2026.
- Per Business Quant, the three latest EBS EPS (Basic) figures stand at $0.13 (Q1 2026), -$1.02 (Q4 2025), and $0.96 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | 0.96 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | 1.25 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | 2.16 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | -0.97 |
| Sep 30, 2023 | -5.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -3.71 |
| Dec 31, 2022 | -1.34 |
| Sep 30, 2022 | -1.75 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | 3.33 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | 0.09 |